Forty-two years ago, a sisterly promise ignited a spark that would fuel a global crusade against breast cancer. Today that promise continues to prevail as the driving force behind Susan G. Komen’s unwavering quest for a future free from the grip of this deadly disease. In the pursuit of our goals, we’ve helped fuel research, unlocking the biology of breast cancer and discovering insights that propel us toward more effective risk reduction strategies, earlier detection methods and innovative treatments. This helped reduce breast cancer mortality by more than 42%. To date, we’ve invested nearly $3.6 billion in groundbreaking research, community health outreach, advocacy and programs in more than 60 countries. Due to investments in research, 19 new drugs for breast cancer were approved in the past decade, and Komen is proud to have been a catalyst for these discoveries. We stand firm in our promise to never give up on our vision of creating a world without breast cancer.